Day 1

Day 2

Day 3

Speakers

Hotel

DAY 1: Saturday 13th October, 2012

2nd Abu Dhabi Advanced Rheumatology Review Course
Programme Agenda for the 1st Day
Main Sessions – Al Sakr Ballroom

Time Agenda Speakers
07.30 – 08.30 Registration Opens
08.35 – 08.45 Course Welcome and Introduction Mustafa Al-Maini, MD
Session 1 Vasculitis
08:45 – 09:45 Systemic Vasculitis – what’s new in 2012? David Scott, MD
09:45 – 10:45 2012 Provisional Classification Criteria for Polymyalgia Rheumatic Bhaskar Dasgupta, MD
10:45 – 11:00 COFFEE BREAK
Session 2 Rheumatology Speciality Clinics
11:00 – 12:00 Comorbidities in Rheumatic Diseases: 2012 Update for Rheumatologists Ian Bruce, MD
12:00 – 13:00 Pregnancy in Connective Tissue Diseases Munther Khamashta, MD
13:00 – 14:00 LUNCH BREAK
Session 3 Industry Symposium
14:00 – 15:00 Janssen Symposium
15:00 – 15:30 COFFEE BREAK
Meet the Professor Workshops
15:30- 16:30 Vasculitis – Sakr Ballroom A Room David Scott, MD
Difficult Lupus – Sakr Ballroom C Room Robert Lahita, MD
Pregnancy in Connective Tissue Diseases – Al Reem A Meeting Room Munther Khamashta,MD
Medical Problems in Rheumatic Diseases – Sir Baniyas Meeting Room Ian Bruce, MD
Ultrasound in Vasculitis – Yas Meeting Room Bhaskar Dasgupta, MD
Rheumatoid Arthritis Registries (by invitation ) – Sadiyat Meeting Room Claire Bombardier, MD
16:30 End of Day 1
Time Agenda Speakers

DAY 2: Sunday 14th October, 2012

2nd Abu Dhabi Advanced Rheumatology Review Course
Programme Agenda for the 2nd Day
Main Sessions – Al Sakr Ballroom

Time Agenda Speakers
07.30 – 08.30 Registration Opens
08.35 – 08.45 Opening Remarks Mustafa Al-Maini, MD
Session 4 Pediatric Rheumatology
08:45 – 09:45 Juvenile Inflammatory Arthritis : New Horizon Angelo Ravelli, MD
09:45 – 10:45 Lupus in Children: what is new ? Hermine Brunner, MD
10:45 – 11:00 COFFEE BREAK
Session 5 Inflammatory Arthritis
11:00 – 12:00 Treatment update of Psoriatic Arthritis : what is the guideline? Philip Helliwell, MD
12:00 – 13:00 What did we learn from biologic registries in Rheumatoid Arthritis Claire Bombardier, MD
13:00 – 14:00 LUNCH BREAK
Session 6 Soft Tissue Rheumatism
14:00 – 15:00 Pain management in rheumatic diseases Serge Perrot, MD
15:00 – 16:00 Evidence Based Medicine: Platelet Rich Plasma in treatment of tendinopathy Nicola Maffulli, MD
16:00 – 16:30 COFFEE BREAK
Meet the Professor Workshops
16:30- 17:30 Lupus – Al Reem A Meeting Room Berva Hann, MD
Pediatric Rheumatology – Sadiyat Meeting Room Hermine Brunner, MD
Pediatric Rheumatology – Yas Meeting Room Angelo Ravelli, MD
Psoriatic Arthritis – Sakr Ballroom C Room Philip Helliwell, MD
Osteoarthritis – Sakr Ballroom A Room Serge Perrot, MD
Fibromyalgia – Sir Baniyas Meeting Room Rinie Geenen, MD
17:30 End of Day 2  
20:00 Gala Dinner – Falcon Lawn, Fairmont Bab Al Bahr
Time Agenda Speakers

DAY 3: Monday 15th October, 2012

2nd Abu Dhabi Advanced Rheumatology Review Course
Programme Agenda for the 3rd Day
Main Sessions – Al Sakr Ballroom

Time Agenda Speakers
07.30 – 08.30 Registration Opens
08.35 – 08.45 Opening Remarks Mustafa Al-Maini, MD
Session 7 Lupus
08:45 – 09:45 Guidelines for screening, diagnosis, treatment and monitoring for lupus nephritis Bevra Hann, MD
09:45 – 10:45 Future therapies for lupus: What Abu Dhabi should know? Robert Lahita, MD
10:45 – 11:00 COFFEE BREAK
Session 8 The Rheumatologist Dilemmas
11:00 – 12:00 Glucocorticoid Induced Osteoporosis David Reid, MD
12:00 – 13:00 Fatigue in rheumatic diseases: mechanisms and treatment Rinie Geenen, MD
13:00 – 14:00 LUNCH BREAK
Session 9 Antiphospholipid Syndrome
14:00 – 15:00 What you should know about APLS in 2012 Munther Khamashta, MD
15:00 – 15:30 COFFEE BREAK
Meet the Professor Workshops
15:30 – 16:30 Lupus Nephritis – Sakr Ballroom A Room Berva Hann, MD
Difficult Lupus – Sakr Ballroom C Room Robert Lahita, MD
Fibromyalgia – Al Reem A Meeting Room Rinie Geenen, MD
Pediatric Rheumatology – Yas Meeting Room Angelo Ravelli, MD
Osteoporosis – Sir Baniyas Meeting Room David Reid, MD
Pediatric Rheumatology – Sadiyat Meeting Room Hermine Brunner, MD
1630 -1640 Closing Remarks Mustafa Al-Maini, MD
16:40 End of Day 3
Time Agenda Speakers

Guest Speakers

Angelo Ravelli, MD, Italy

ar

Field of clinical and research activity

Pediatric Rheumatology

Academic and clinical position

Associate Professor of Pediatrics, Department of Pediatrics, University of Genoa, Italy
Chief, Interventional Rheumatology Unit, IRCCS G. Gaslini, Genoa, Italy

Study stages in foreign institutions

Department of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden
Division of Rheumatology, Childrens Hospital Los Angeles, California, USA
Division of Rheumatology, Hospital for Sick Children, Toronto, Canada

Editorial activity

Associate Editor, Pediatric Rheumatology Online Journal
Assistant Editor, Clinical and Experimental Rheumatology
Co-Editor, Annals of Paediatric Rheumatology
Editorial Board member, The Journal of Rheumatology
Editorial Board Member, Arthritis Care & Research
Reviewer for more than 40 international scientific journals

International meetings/workshops organization

Member of the scientific committee of 12 international meetings or workshops

International meetings/workshops/lecturer activity

Invited speaker in more than 90 national meetings
Invited speaker in more than 60 international meetings
Invited expert in 20 international workshops
Invited lecturer in 11 international institutions

Publications

Author or co-author of more than 200 full-length articles in international scientific
journals with a total impact factor of more than 900 and an H-index of 40.


Bevra H. Hahn, MD, US

bh2Bevra H. Hahn is Professor Emeritus of Medicine at the David Geffen School of Medicine, University of California Los Angeles. She was the Vice-Chair of the Department of Medicine, and Chief of Rheumatology at the David Geffen School of Medicine, University of California Los Angeles, from 1983 to 2012. A summa-cum-laude graduate of Ohio State University, Dr. Hahn received her medical degree from Johns Hopkins. She has been elected to Phi Beta Kappa, Alpha Omega Alpha, the American Society of Clinical Investigators, the Association of American Physicians and the Johns Hopkins Society of Scholars. She did an internship and residency in medicine in St. Louis at Barnes Hospital, Washington University. She is past-president of the American College of Rheumatology (ACR) and is currently a Master. She serves as the Chair of the NIH/NIAID Immune Tolerance Network Data and Safety Monitoring Board, and member of the Council of Councils, which is advisory to the Director of the NIH. Among her awards are the Dunlop-Dottridge Award of the Canadian Rheumatism Association for research in rheumatology, the Joseph Bunim Medal and prize of the American College of Rheumatology, the Holley Research prize in Rheumatology, the Southern California Arthritis Foundation’s Klinenberg Medal for Arthritis Research, the Carol-Nachman International Award for Rheumatology Research, the first Evelyn V Hess Award of the Lupus Foundation of America for research in SLE, the 2007 ACR/REF Award of Distinction for Academic Mentoring, and the 2009 ACR Gold Medal. Dr. Hahn has authored more than 130 peer-reviewed research papers including the recently published ACR Lupus Nephritis Treatment Guidelines and over 40 book chapters or reviews as well as serving as co-editor of an influential textbook Dubois’ Lupus Erythematosus. She has served on the editorial boards of the Journal of Clinical Investigation and the Annals of Internal Medicine. Her current research at the Laboratory for Lupus Research at UCLA includes investigations in immune tolerance, regulatory CD4+ and CD8+ T cells, genetics, accelerated atherosclerosis and treatment of systemic lupus. The laboratory is funded by grants from the National Institutes of Health, the Arthritis Foundation (Southern California Chapter), the American College of Rheumatology/Research Education Foundation, a Lupus Clinical Trials Center award, Rheuminations and private donors including Jeanne Rappaport.


Bhaskar Dasgupta, MD, PhD, UK

bdProfessor Dasgupta is the Head of the Rheumatology and Clinical Director of Research & Audit at Southend University Hospital and holds a Professorship at Essex University.

He has had a lifelong interest in Polymyalgia Rheumatica and Giant Cell Arteritis and has published numerous articles on these topics. As Convenor he developed the British Society of Rheumatology guidelines on PMR and GCA which have now been adopted by GP’s in the United Kingdom.

Professor Dasgupta is a lead Investigator for the development of EULAR and ACR classification criteria for PMR. This prospective study has also led to validation of patient reported outcome measures for the assessment of PMR. Professor Dasgupta leads on several new clinical trials in both PMR and GCA.

Professor Dasgupta has had a longstanding interest in musculoskeletal and temporal artery ultrasonography. He has lectured on the topic at international meetings and regularly hosts national and regional courses. He is a lead investigator for a UK multicentre Study comparing the diagnostic accuracy of temporal artery ultrasound versus temporal artery biopsy in patients with suspected Giant Cell Arteritis.


Claire Bombardier, MD, PhD, Canada

cbDr. Claire Bombardier is a Professor of Medicine at the University of Toronto, where she was the founding director of the Clinical Epidemiology Program and holds a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care as well as a Pfizer Research Chair in Rheumatology. Dr. Bombardier is rheumatologist at Mount Sinai Hospital and the Rheumatology Division Director for the University of Toronto. She is a Senior Scientist at the Toronto General Research Institute and at the Institute for Work & Health (an independent, not-for-profit research organization), where she is also co-editor of the Cochrane Back Review Group. Currently, she serves as a Co-Scientific Director Canadian Arthritis Network (CAN), also a not-for-profit organization that supports integrated, trans-disciplinary research and development.

Professional interests include the improvement of clinical effectiveness, optimum use of technology and drugs, clinical economics, performance measurement/program evaluation, health research methods (clinical trials), knowledge transfer and workplace/rehabilitation, with a focus on musculoskeletal disorders. She has published more than 300 articles in scholarly journals and is the recipient of numerous competitive awards and grants.


David M Reid, MD, PhD, UK

drProfessor David M Reid holds a personal chair of Rheumatology and is Head of the School of Medicine & Dentistry University of Aberdeen.

He has over 270 original papers and reviews, largely on his current research interests which include the utility of bone mass assessment, assessment of risk of fracture, secondary osteoporosis and the assessment of long-term disease activity and drug adverse effects in rheumatic diseases.
He is the immediate past Chairman of the Board of Trustees of the UK National Osteoporosis Society (NOS) and has previously chaired their Research Grants Committee and Medical Board. For the last 4 years he has been the chair of the Arthritis Research UK Clinical Studies Group with responsibility for advising on the needs for clinical trials in bone diseases.


David G I Scott, MD, UK

dsDavid G I Scott was appointed Consultant Rheumatologist at the Norfolk & Norwich University Hospital NHS Foundation Trust in February 1988. He retired from his NHS clinical work in 2011 and is currently Hon Consultant. He was Director of Research and Development for the Trust from 1996 to May 2006 and was made Honorary Professor to the UEA in 1998. He held the post of Divisional Clinical Director for Medicine in the Trust from May 2006 to July 2007 and was appointed Director of the Norfolk and Suffolk CLRN in August 2007.

David graduated from Bristol in 1973 and undertook junior doctor training in Southampton, Bristol, Bath and Birmingham, completing an MD on systemic vasculitis in 1981.
He was President of the British Society for Rheumatology (BSR) from 2002 to 2004 and Chair of the Joint Specialty Committee for Rheumatology, linking the BSR with the Royal College of Physicians (RCP) 2002-2006. He was elected to Council of the RCP in 2004 and significantly contributed to the RCP working party on Medical Professionalism. He was RCP Patient Involvement Officer from 2007-2011.

Previous activities include Medical Secretary to the Arthritis Research Campaign (arc) and until recently the arc Scientific Co-ordinating Committee. He is chair of the arc Research and Academic Capacity Committee (2008– present) and is Medical Adviser to two charities; NRAS (now Chief Medical Adviser) and the Raynaud’s and Scleroderma Association.
He has a long-standing interest in systemic vasculitis, and has written over 250 reviews/editorials and papers in total, including clinical aspects, epidemiology and outcome, and lectures nationally and internationally on this subject. Other research interests include epidemiology of rheumatoid arthritis (Norfolk Arthritis Register) and clinical, health economic and psychosocial aspects of inflammatory arthritis including their relevance to the introduction of anti-TNF alpha therapy.


Hermine Brunner, MD, PhD, US

bhDr. Brunner is a Professor of Pediatrics at the Cincinnati Children’s Hospital Medical Center. She trained in Germany where she received her medical and business degree, in Canada and the United States for her pediatric and rheumatology training. She earned a Master’s Degree in Clinical Epidemiology from the University of Toronto. Since 2000, she serves as the Director of the local Lupus center at the Cincinnati Children’s Hospital Medical Center which ranks third in among the pediatric hospitals in the U.S.

She has a research interest in translational and clinical research with focus on lupus in children. As such has authored over 80 peer-reviewed publications, chapters and reviews.


Ian Bruce, MD, PhD, US

ibIan Bruce is Professor of Rheumatology at the Arthritis Research UK Epidemiology Unit, Institute of Inflammation and Repair, The University of Manchester and Medical Director of The Manchester Wellcome Trust Clinical Research Facility. He is also Lead Clinician at The Kellgren Centre for Rheumatology, Central Manchester University Hospitals Foundation Trust (CMFT) and the Manchester Centre Academic Lead for the NIHR Translational Research Partnership for Joint and Related Inflammatory Diseases.

His major research focus is on systemic lupus erythematosus (SLE) and RA and he is particularly interested in cardiovascular outcomes in rheumatic diseases. As a member of the British Isles Lupus Assessment Group (BILAG) and The Systemic Lupus International Collaborating Clinics (SLICC- vice chair) he has been involved in the development and validation of the key clinical outcome measures used in SLE research.

His group has a well defined SLE cohort with 250 patients recruited with standardised SLE clinical assessments, cardiovascular risk factors, subclinical atherosclerosis and quality of life measures. His RA work includes studies of cardiovascular outcomes in the Norfolk Arthritis Register (NOAR) and he is a Co-PI in an MRC/ABPI I+I initiative ‘Towards a Cure for Rheumatoid Arthritis’. Professor Bruce’s group have described impaired endothelial function in SLE patients as well as a high burden of carotid plaque in the SLE population. This work also highlighted how vitamin D status is associated with increased aortic stiffness. Recent studies have demonstrated impaired vascular repair mechanisms in SLE, and how serological status in early RA is associated with increased insulin resistance.


Munther Khamashta, MD, PhD, UAE

mkMunther Khamashta, MD, PhD, FRCP is Professor/Consultant Physician and Director of The Lupus Research Unit at St Thomas’ Hospital, London, and runs a large lupus pregnancy clinic.

He studied medicine in Barcelona, Spain and internal medicine in Madrid, where he developed an interest in connective tissue diseases and received a PhD. He was awarded the MRCP in 1999 and FRCP in 2002. He joined the Lupus Unit in London 25 years ago and has been instrumental in developing it into an internationally recognised tertiary centre receiving referrals from all over the United Kingdom.

Professor Khamashta has served on the Editorial Boards of many journals, including Clinical & Experimental Rheumatology, Lupus, and Current Rheumatology Reviews. He is a member of several professional societies, including the International Society of Internal Medicine, the American College of Rheumatology, and the Spanish Society of Rheumatology. He is a member of the Steering Committee of the International Board on the Study of Antiphospholipid Antibodies and of the Steering Committee of the International Advisory Board for SLE. He has received several international awards for his work in lupus, including European League Against Rheumatism (EULAR) and International League Against Rheumatism (ILAR) prizes.

Professor Khamashta has a strong research interest in lupus and connective tissue diseases, with a special interest in pregnancy and antiphospholipid syndrome. He has published extensively in lupus, Hughes’ syndrome, and related areas, with more than 500 original papers, and 750 abstracts presented at national and international meetings. He has also published several books.


Nicola Maffulli, MD, PhD, UK

nmProfessor Nicola Maffulli is widely recognised as one of the world’s most eminent Consultant Orthopaedic and Sports Injury Surgeons.

He is responsible for pioneering revolutionary new procedures and techniques in foot and ankle surgery, and he is responsible for fixing some of the UK’s top sportsmen and women, including Premiership football players as well as Track and field Athletes and international rugby players.

Apart from being one of the world’s top surgeons and lecturers in this field, Professor Maffulli has published well over 700 peer reviewed articles in scientific journals. In addition, he has published nine books on Orthopaedic Surgery and in Sports Medicine.

Professor Maffulli has particular scientific interest in physiopathology of sports injuries, including anterior cruciate ligament and tendon injuries, and great expertise in arthroscopic techniques of the knee and foot and ankle. Given these extra curricular activities and the heavy clinical workload that has characterised his career thus far, the Prof has developed subspecialty interests and focuses in the following areas: Foot and ankle surgery, Sports trauma, Deformity correction and Complex trauma, knee and ankle arthroscopy, minimally invasive surgery of the knee and foot and ankle. He is now Centre Lead and Professor of Sports and Exercise Medicine, at Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Centre for Sports and Exercise Medicine, and Consultant Trauma and Orthopaedic Surgeon at Mile End Hospital, London. and Newham University Hospital, London.


Philip Helliwell, MD, UK

phPhilip Helliwell is currently Senior Lecturer in Rheumatology at the University of Leeds, in the UK, and Honorary Consultant Rheumatologist for the Bradford Hospitals NHS Trust.

Previous appointments include: Member of NHS R&D Research Committee on Physical and Complex Disabilities, Member of the Executive Council, Centre for Biomechanics and Medical Engineering; Treasurer and Member of Executive Committee, Society for Back Pain Research; Member of Education Committee, Arthritis Research Campaign; and Editor for the ARC Patient Information Leaflets and Convener Publications Working Group.

His main research interest is in treatment paradigms, clinical features and classification of psoriatic arthritis. He was a founding member of the GRAPPA group in 2003 and served on the Executive Committee until 2008. He was the PI of the CASPAR study in 2001 and is now leading the GRAPPA composite outcome measure study.

Between 1997 and 2000, Dr Helliwell was a Member of the Heberden Committee, at the British Society for Rheumatology where he was involved in research, training and educational matters. He was also a Member of Council at the British Society for Rheumatology.

Dr Helliwell is also a referee for MRC, EPSRC, ARC and several European and North American Journals.


Rinie Geenen, MD, PhD, Netherlands

rgProfessor Rinie Geenen, psychologist, is head of the Psychorheumatology research unit at the Department of Clinical and Health Psychology of Utrecht University and the Department of Rheumatology and Clinical Immunology of the University Medical Center Utrecht in Utrecht, The Netherlands. The focus of his research is on the mutual interaction between biological, psychological and social factors in rheumatic diseases. Recent publications are about lack of understanding for invisible symptoms that patients may be confronted with, and about mechanisms of and interventions against depression, pain, and fatigue in rheumatic diseases.

Publications: www.RinieGeenen.nl


Robert Lahita, MD, PhD, US

lrRobert Lahita MD, PhD, FACP, MACR, FRCP, is an adjunct Professor of Medicine at Mount Sinai Medical School and Professor of Medicine at UMDNJ. Dr. Lahita is also adjunct Professor of Biochemistry and Molecular Biology at UMDNJ. He is Chairman of Medicine at the Newark Beth Israel Hospital and Vice President. He is currently a senior attending physician at Newark Beth Israel Hospital.

Dr. Lahita earned his medical Degree from the Jefferson Medical College and his doctorate in microbiology from the Thomas Jefferson University in Philadelphia. He received his postgraduate training in internal medicine at New York Hospital- Memorial Sloan Kettering Hospital for Cancer and Allied Diseases. He later joined the laboratory of Henry G. Kunkel at the Rockefeller University as Research Associate and Post doctoral Fellow in the Department of Immunology. Dr. Lahita rose to the rank of Associate Professor at Rockefeller and subsequently became the Chief of Rheumatology at Saint Luke’s Roosevelt Hospital in New York and Associate Professor at Columbia University. Later he left Saint Luke’s Hospital and became Professor of Medicine at the New York Medical College and Chief of Rheumatology at Saint Vincent’s Hospital in NYC. After 911, Dr. Lahita moved his practice and research to New Jersey. His current academic position is Professor of Medicine at University of Medicine and Dentistry of NJ and Adjunct Professor of Molecular Biology and Biochemistry.

In addition to his academic and medical appointments, Dr. Lahita has written, co written, edited, and co edited numerous books on the topic of lupus, including Lupus: Everything You Want to Know. His most recent work is his book entitled Women and Autoimmune Disease, your body betrayed, from Harper Collins. He serves as the Editor of the Yearbook of Rheumatology, Orthopedics and Women’s Health, Associate Editor of the Journal Lupus and is on numerous other editorial boards. He is also the editor of the standard textbook called Systemic Lupus Erythematosus (5th edition 2011) and the Textbook of Autoimmune Diseases.

The recipient of numerous research grants from the Primus Foundation, the Lupus Foundation of America and the National institutes of Health, Dr. Lahita is internationally recognized for his clinical research in systemic lupus erythematosus and autoimmune diseases. His findings have been the subject of more than 170 published research articles and book chapters and over fourteen books. Currently Dr. Lahita’s interests include the role of sex hormones on apoptosis, the association of gonadal pathology in women with the onset of autoimmunity, and autoimmunity in men, and modulation of interferon regulatory factor 5 as a target in the treatment of autoimmune disease.

Dr. Lahita has appeared on CBS This Morning, MSNBC, FOX news, Good Morning America, Regis and Kelly, Heraldo, Entertainment tonight, Access Hollywood and Health on 12 (NJ).


Serge Perrot, MD, PhD, France

spProfessor Serge Perrot is a rheumatologist with a special interest in pain management. He currently heads the pain clinic of the Hôtel-Dieu Hospital, the oldest hospital of Paris, in France. Professor Perrot is the founder and current vice-president of the French group of rheumatic pain specialists (CEDR), an organization that links the French Society of Rheumatology (SFR) with the French Pain Society (SFETD). He is in charge of coordination of teaching Pain Medicine at Paris Descartes University.

He has participated in several workshops to establish national and international guidelines on pain management, especially on back pain. He has co-ordinated more than 50 studies on rheumatology in the field of pain. Professor Perrot has worked on morphine and inflammation for several years at the French national medical research institute (Institut National de la Santé et de la Recherche Médicale [Inserm]). His primary areas of interest are morphine and opioids in rheumatology, rheumatological pain conditions like fibromyalgia, low back pain and complex regional pain syndromes. He has developed a screening tool in fibromyalgia, the FiRST (Fibromyalgia Rapid Screening Tool).

He is currently expert at the French Drug Agency for analgesics, member of different editorial boards of pain journals. He is member of international scientific societies in pain and rheumatology: IASP and EULAR.


Fairmont Bab Al Bahr, Abu Dhabi

The Fairmont Bab Al Bahr is an elegant, modern hotel whose spectacularly lit exterior has become an established city landmark. Located between the international airport and the city centre, the hotel borders a creek that separates Abu Dhabi city from the mainland, with views across to the stunning Sheikh Zayed Mosque.

The contemporary interior houses a range of fine dining restaurants and bars, popular with guests and locals alike. Leisure facilities include a gym and an outdoor pool while the hotel can help arrange sightseeing and sporting activities in the capital.

For more information, visit www.fairmont.com/babalbahr